Yao R, Sun L, Gao R, Mei Y, Xue G, Yu D
Brief Bioinform. 2025; 26(1).
PMID: 39924716
PMC: 11807729.
DOI: 10.1093/bib/bbaf057.
Xiao X, Long F, Yu S, Wu W, Nie D, Ren X
Front Immunol. 2025; 15():1496090.
PMID: 39845977
PMC: 11750837.
DOI: 10.3389/fimmu.2024.1496090.
Pinkney H, Ross C, Hodgson T, Pattison S, Diermeier S
NPJ Precis Oncol. 2024; 8(1):230.
PMID: 39390212
PMC: 11467462.
DOI: 10.1038/s41698-024-00728-1.
Xiao Y, Lai C, Hu J, Mulati Y, Xu X, Luo J
BMC Cancer. 2024; 24(1):1038.
PMID: 39174928
PMC: 11342612.
DOI: 10.1186/s12885-024-12783-9.
Macdonald J, Taylor H, Wang M, DelaCourt A, Edge C, Lewin D
J Proteome Res. 2024; 23(9):3791-3805.
PMID: 38980715
PMC: 11385377.
DOI: 10.1021/acs.jproteome.4c00099.
Analysis of tumor microenvironment alterations in partially responsive rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Chen H, Zhang J, Hao Q, Wu X, Guo J, Huang C
Int J Colorectal Dis. 2024; 39(1):99.
PMID: 38926205
PMC: 11208236.
DOI: 10.1007/s00384-024-04672-1.
Unveiling Collagen's Role in Breast Cancer: Insights into Expression Patterns, Functions and Clinical Implications.
Li X, Jin Y, Xue J
Int J Gen Med. 2024; 17:1773-1787.
PMID: 38711825
PMC: 11073151.
DOI: 10.2147/IJGM.S463649.
CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p.
Liu J, Zhang X, Yang M, Zhang X
J Cancer Res Clin Oncol. 2024; 150(4):211.
PMID: 38662258
PMC: 11045592.
DOI: 10.1007/s00432-024-05736-z.
MiRNA-766-3p inhibits gastric cancer via targeting COL1A1 and regulating PI3K/AKT signaling pathway.
Ding Y, Zhang M, Hu S, Zhang C, Zhou Y, Han M
J Cancer. 2024; 15(4):990-998.
PMID: 38230216
PMC: 10788715.
DOI: 10.7150/jca.90321.
Decellularized diseased tissues: current state-of-the-art and future directions.
Li X, Shan J, Chen X, Cui H, Wen G, Yu Y
MedComm (2020). 2023; 4(6):e399.
PMID: 38020712
PMC: 10661834.
DOI: 10.1002/mco2.399.
Intercellular Molecular Crosstalk Networks within Invasive and Immunosuppressive Tumor Microenvironment Subtypes Associated with Clinical Outcomes in Four Cancer Types.
Wei J, Yu W, Wu L, Chen Z, Huang G, Hu M
Biomedicines. 2023; 11(11).
PMID: 38002057
PMC: 10669098.
DOI: 10.3390/biomedicines11113057.
hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression.
Liu L, Huang W
Cancer Biol Ther. 2023; 24(1):2274120.
PMID: 37978903
PMC: 10761020.
DOI: 10.1080/15384047.2023.2274120.
Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.
Hosseini S, Nemati F
Sci Rep. 2023; 13(1):17086.
PMID: 37816854
PMC: 10564945.
DOI: 10.1038/s41598-023-44459-y.
ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma.
Yuan X, He Y, Wang W
Sci Rep. 2023; 13(1):16932.
PMID: 37805556
PMC: 10560230.
DOI: 10.1038/s41598-023-43507-x.
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon A, Lyu S, Laible M, Woll S, Tureci O, Sahin U
J Transl Med. 2023; 21(1):552.
PMID: 37592303
PMC: 10436499.
DOI: 10.1186/s12967-023-04433-8.
Reviewing the Regulators of COL1A1.
Devos H, Zoidakis J, Roubelakis M, Latosinska A, Vlahou A
Int J Mol Sci. 2023; 24(12).
PMID: 37373151
PMC: 10298483.
DOI: 10.3390/ijms241210004.
Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer.
Couto J, Vulin M, Jehanno C, Coissieux M, Hamelin B, Schmidt A
EMBO J. 2023; 42(13):e112559.
PMID: 37259596
PMC: 10308372.
DOI: 10.15252/embj.2022112559.
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and in Metastasis.
Xiao J, Sharma U, Arab A, Miglani S, Bhalla S, Suguru S
Cancers (Basel). 2023; 15(6).
PMID: 36980717
PMC: 10046547.
DOI: 10.3390/cancers15061831.
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities.
Lopez-Camacho E, Prado-Vazquez G, Martinez-Perez D, Ferrer-Gomez M, Llorente-Armijo S, Lopez-Vacas R
Cancers (Basel). 2023; 15(4).
PMID: 36831448
PMC: 9953902.
DOI: 10.3390/cancers15041104.
The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer.
Yimamu Y, Yang X, Chen J, Luo C, Xiao W, Guan H
J Clin Med. 2022; 11(23).
PMID: 36498737
PMC: 9737657.
DOI: 10.3390/jcm11237164.